A comparison of affected and unaffected relatives of patients with bipolar disorder using proton magnetic resonance spectroscopy

Journal of Psychiatry and Neuroscience

Volumn 33, Issue 6, 2008, Pages 531-540

  Hajek, Tomas ^a,d   Benier, Denise ^a   Slaney, Claire ^a   Proper, Lukas ^a   Schmidt, Matthias ^a   Carrey, Normand ^a   McQueen, Glenda ^b   MacQueen, Glenda ^b   Duffy, Anne ^c   Alda, Martin ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Bipolar disorders; Magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATINE; INOSITOL; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; AGE; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CONTROLLED STUDY; FAMILY; FAMILY HISTORY; FEMALE; GENDER; GENETIC RISK; GRAY MATTER; HEMISPHERE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METABOLITE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE; RELATIVE;

EID: 56349170832     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. McGuffin P, Rijsdijk F, Andrew M, et al. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 2003;60:497-502.
2. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003;160:636-45.
3. Bechara A, Tranel D, Damasio H, et al. Failure to respond autonomically to anticipated future outcomes following damage to prefrontal cortex. Cereb Cortex 1996;6:215-25.
4. Drevets WC, Ongur D, Price JL. Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol Psychiatry 1998;3:220-1.
5. Hirayasu Y, Shenton ME, Salisbury DF, et al. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 1999;156: 1091-3.
6. Wilke M, Kowatch RA, DelBello MP, et al. Voxel-based morphometry in adolescents with bipolar disorder: first results. Psychiatry Res 2004;131:57-69.
7. Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 2001;49:741-52.
8. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 1998; 95:13290-5.
9. Benes FM, Vincent SL, Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry 2001;50:395-406.
10. Krüger S, Alda M, Young LT, et al. Risk and resilience markers in bipolar disorder: brain responses to emotional challenge in bipolar patients and their healthy siblings. Am J Psychiatry 2006;163:257-64.
11. Cecil KM, DelBello MP, Morey R, et al. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord 2002;4:357-65.
12. Davanzo P, Yue K, Thomas MA, et al. Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents. Am J Psychiatry 2003;160:1442-52.
13. Davanzo P, Thomas MA, Yue K, et al. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 2001;24:359-69.
14. Moore CM, Breeze JL, Gruber SA, et al. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord 2000;2(3 Pt 2):207-16.
15. Sassi RB, Stanley JA, Axelson D, et al. Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients. Am J Psychiatry 2005;162:2109-15.
16. Cecil KM, DelBello MP, Sellars MC, et al. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders. J Child Adolesc Psychopharmacol 2003;13:545-55.
17. Castillo M, Kwock L, Courvoisie H, et al. Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations. AJNR Am J Neuroradiol 2000;21:832-8.
18. Chang K, Adleman N, Dienes K, et al. Decreased N-acetylaspartate in children with familial bipolar disorder. Biol Psychiatry 2003;53: 1059-65.
19. Gallelli KA, Wagner CM, Karchemskiy A, et al. N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder. Bipolar Disord 2005;7:589-97.
20. Duffy A, Alda M, Kutcher S, et al. A prospective study of the offspring of bipolar parents responsive and nonresponsive to lithium treatment. J Clin Psychiatry 2002;63:1171-8.
21. Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978;35: 837-44.
22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: The Association; 1994.
23. Todd RD, Reich W, Petti TA, et al. Psychiatric diagnoses in the child and adolescent members of extended families identified through adult bipolar affective disorder probands. J Am Acad Child Adolesc Psychiatry 1996;35:664-71.
24. Gershon ES, Hamovit J, Guroff JJ, et al. A family study of schizo-affective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry 1982;39:1157-67.
25. Winsberg ME, Sachs N, Tate DL, et al. Decreased dorsolateral prefrontal N-acetylaspartate in bipolar disorder. Biol Psychiatry 2000; 47:475-81.
26. Kato T, Hamakawa H, Shioiri T, et al. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. J Psychiatry Neurosci 1996;21:248-54.
27. Hamakawa H, Kato T, Murashita J, et al. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. Eur Arch Psychiatry Clin Neurosci 1998;248:53-8.
28. Dager SR, Friedman SD, Parow A, et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 2004;61:450-8.
29. Wu RH, O'Donnell T, Ulrich M, et al. Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate. Ann Gen Hosp Psychiatry 2004;3:13.
30. Silverstone PH, Asghar SJ, O'Donnell T, et al. Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients. World J Biol Psychiatry 2004;5:38-44.
31. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed., revised. Washington: The Association; 1987.
32. McGrath BM, Wessels PH, Bell EC, et al. Neurobiological findings in bipolar II disorder compared with findings in bipolar I disorder. Can J Psychiatry 2004;49:794-801.
33. Brambilla P, Stanley JA, Nicoletti MA, et al. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. J Affect Disord 2005;86:61-7.
34. Friedman SD, Dager SR, Parow A, et al. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biol Psychiatry 2004;56:340-8.
35. Moore GJ, Bebchuk JM, Hasanat K, et al. Lithium increases N-acetylaspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 2000;48:1-8.
36. Kaufman J, Birmaher B, Brent D, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997;36:980-8.
37. McLean MA, Woermann FG, Barker GJ, et al. Quantitative analysis of short echo time (1)H-MRSI of cerebral gray and white matter. Magn Reson Med 2000;44:401-11.
38. Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996;29:162-73.
39. Gispert JD, Reig S, Pascau J, et al. Method for bias field correction of brain T1-weighted magnetic resonance images minimizing segmentation error. Hum Brain Mapp 2004;22:133-44.
40. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001;14:260-4.
41. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-9.
42. Kreis R. Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR Biomed 2004; 17:361-81.
43. Gruber S, Frey R, Mlynarik V, et al. Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla. Invest Radiol 2003;38:403-8.
44. DelBello MP, Cecil KM, Adler CM, et al. Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study. Neuropsychopharmacology 2006;31:1264-73.
45. Bartha R, Drost DJ, Williamson PC. Factors affecting the quantification of short echo in-vivo 1H MR spectra: prior knowledge, peak elimination, and filtering. NMR Biomed 1999;12:205-16.
46. Bertolino A, Frye M, Callicott JH, et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 2003;53:906-13.
47. Deicken RF, Pegues MP, Anzalone S, et al. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. Am J Psychiatry 2003;160:873-82.
48. Sharma R, Venkatasubramanian PN, Barany M, et al. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophr Res 1992;8:43-9.
49. Hillegers MH, Reichart CG, Wals M, et al. Five-year prospective outcome of psychopathology in the adolescent offspring of bipolar parents. Bipolar Disord 2005;7:344-50.
50. Blacker D, Tsuang MT. Unipolar relatives of bipolar pedigrees: Are they bipolar? Psychiatr Genet 1993;3:5-16.
51. Frye MA, Watzl J, Banakar S, et al. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology 2007;32:2490-9.
52. Frye MA, Thomas MA, Yue K, et al. Reduced concentrations of N-acetylaspartate (NAA) and the NAA-creatine ratio in the basal ganglia in bipolar disorder: a study using 3-Tesla proton magnetic resonance spectroscopy. Psychiatry Res 2007;154:259-65.
53. Silverstone PH, Wu RH, O'Donnell T, et al. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetylaspartate concentrations in euthymic bipolar patients. Int Clin Psychopharmacol 2003;18:73-9.
54. Gonul AS, Kitis O, Ozan E, et al. The effect of antidepressant treatment on N-acetylaspartate levels of medial frontal cortex in drugfree depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:120-5.
55. Moore CM, Biederman J, Wozniak J, et al. Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study. Am J Psychiatry 2006;163:316-8.
56. Moore CM, Biederman J, Wozniak J et al. Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex. J Affect Disord 2007;99:19-25.